University of Wisconsin–Madison
Fariba Assadi-Porter

Fariba Assadi-Porter

Fariba Assadi-Porter

Research

Google Scholar

My research focuses on the mechanisms underlying early disease detection and disease progression using stable isotope technology and metabolomics. By integrating these complementary approaches, my work has identified metabolic biomarkers that reveal early physiological responses to infection and metabolic dysfunction, enabling pre-symptomatic disease detection. This research has led to patented breath-analysis technologies that measure stable carbon isotope signatures in breath to detect disease-related metabolic changes in under one minute and is being translated into applications for animal and human health.

A flow chart depicting how breath-analysis technology was developed to detect early physiological changes associated with disease.
Breath-analysis technology developed from stable isotope and metabolomic research. The platform measures stable carbon isotope signatures in exhaled breath as noninvasive biomarkers of metabolic activity. Breath samples are analyzed in under one minute, securely transmitted for automated processing, and interpreted using proprietary algorithms to detect early physiological changes associated with infectious and metabolic diseases before clinical signs become apparent.